4.3 Review

Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria

期刊

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
卷 74, 期 6, 页码 679-700

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00228-018-2446-0

关键词

Inappropriate prescribing; Potentially inappropriate medication list; Drug-related side effects and adverse reactions; Aged

资金

  1. Coordination for the Improvement of Higher Education Personnel-CAPES through University of Vale do Rio dos Sinos, Brazil
  2. CAPES through University of Sydney, Australia [88881.134589/2016-01]
  3. National Council for Scientific and Technological Development-CNPQ [426720/2016-4]

向作者/读者索取更多资源

Purpose Potentially inappropriate medication (PIM) use causes preventable adverse drug reactions in older patients. Several assessment tools have been published to identify and avoid PIM use. In this systematic literature review, we aim to provide summaries and comparisons of validated PIMs lists published between 1991 and 2017 internationally. Methods In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement (PRISMA), we performed a systematic review of articles describing the development and validation of criteria for identification of PIMs among older people published between January 1991 and April 2017. The searches were conducted on PUBMED, AgeLine, Academic Search, Academic Search Premier, and CINAHL. We identified the most common medications/classes described as PIM. We also identified the drug-disease interactions and drug-drug interactions reported among criteria. Results From 2933 articles screened, 36 met our inclusion criteria. The majority used the Delphi method to validate their criteria. We identified 907 different medications/classes, 536 different drug disease interactions involving 84 diseases/conditions, and 159 drug-drug interactions. Benzodiazepines and nonsteroidal anti-inflammatory drugs were the medications most commonly reported as potentially inappropriate for older people. Conclusion Although approaches aimed at detecting inappropriate prescribing have intensified in recent years, we observed limited overlap between different PIM lists. Additionally, some PIM lists did not provide special considerations of use and alternative therapies to avoid PIMs. These facts may compromise the use of PIM lists in clinical practice. Future PIM lists should integrate information about alternative therapies and special considerations of use in order to help clinicians in the drug prescription.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据